<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701246</url>
  </required_header>
  <id_info>
    <org_study_id>FANUT 302004</org_study_id>
    <nct_id>NCT00701246</nct_id>
  </id_info>
  <brief_title>Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil</brief_title>
  <official_title>Nutritional Anemia: Prevention and Treatment in Early Childhood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Goias</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Goiania Municipal Health Department</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal de Goias</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iron deficiency anemia is the most common nutritional problem in the world.

      The objectives of this study are:

        -  to evaluate the prevalence of anemia in children from 6 to 24 months of age and the
           therapeutic and prophylactic response to ferrous sulfate plus folic acid on hemoglobin
           levels.

        -  to compare the effect of folic acid supplementation with ferrous sulfate on the linear
           and weight growth of anemic and non-anemic

      Study hypothesis:

        -  The ferrous sulfate plus folic acid can improve the response on hemoglobin levels.

        -  The folic acid supplementation with ferrous sulfate have effect on the linear and weight
           growth of anemic and non-anemic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose

      The objective of this study were:

        -  to assess the prevalence of anemia and the therapeutic and prophylactic response to
           ferrous sulfate and folic acid.

        -  to compare the effect of folic acid supplementation with ferrous sulfate on the linear
           and weight growth of anemic and non-anemic.

      A double-blind, randomized, controlled clinical trial was conducted with 196 children 6 to 24
      months of age enrolled in municipal daycare centers in Goiânia, Goias State, Brazil. The
      children were assigned to two treatment groups that received a daily dose (5 times a week) of
      either 4.2mg/kg/day of ferrous sulfate + folic acid (50μg) or 4.2mg/kg/day of ferrous sulfate
      + folic acid placebo. One of the prevention groups received 1.4mg/kg/day of ferrous sulfate +
      folic acid (50μg/day) and the other 1.4mg/kg/day of ferrous sulfate + folic acid placebo.
      Supplementation lasted approximately three months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Iron status</measure>
    <time_frame>Approximately three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of anemia</measure>
    <time_frame>Approximately three months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Linear ad weight gain of anemic and non-anemic</measure>
    <time_frame>Approximately three months</time_frame>
    <description>Linear and weight gain of anemic and non-anemic observed by anthropometric surveys (Z-score for weight-for-age, Z-score for height-for-age, Z-score for weight-for-height, average monthly weight, monthly length gain, and gain of Z-scores for weight-for-age, height-for-age, weight-for-height)</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">196</enrollment>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>I Treatment: a daily dose (5 times a week) of either 4,2 mg/kg/day of ferrous sulfate + folic acid (50 mcg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>II Treatment of anemic children with 4,2 mg/kg/day of ferrous sulfate and folic acid placebo.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prevention of anemia in non-anemic children ( 5 times a week)- 1,4 mg/kg/day of ferrous sulfate and folic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1,4 mg/kg/day of ferrous sulfate plus folic acid placebo, five days a week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ferrous sulfate</intervention_name>
    <arm_group_label>I</arm_group_label>
    <arm_group_label>II</arm_group_label>
    <arm_group_label>III</arm_group_label>
    <arm_group_label>IV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>folic acid</intervention_name>
    <arm_group_label>I</arm_group_label>
    <arm_group_label>III</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo (folic acid)</intervention_name>
    <arm_group_label>II</arm_group_label>
    <arm_group_label>IV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  from 6 to 24 months

          -  born at term

          -  non-twins

          -  with parental approval for participation in the study

          -  attending municipal daycare centers with mor than four children each

        Exclusion Criteria:

          -  Children with special needs

          -  low birth weight (&lt;2.500g)

          -  with growth-impairing heart diseases

          -  neurological syndromes

          -  sickle-cell anemia

          -  sickle-cell trait

          -  under treatment for anemia at the time of the first interview or screening performed
             by the pediatrician

          -  those no longer attending the daycare center

          -  the clinical trial excluded children with hemoglobin &gt;=7 amd &lt;=8g/dL.

          -  For the second objective: incomplete anthropometric surveys
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Claret CM Hadler, PhD Sciences</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal de Goias</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dirce M Sigulem, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria de Fátima C Alves, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal de Goias</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinícius M Torres, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vila São José Bento Cotolengo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniela AM Dias, MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Nutrition of Federal University of Goias</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andréa Sugai, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Nutrition - Federal University of Goias</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidade Federal de Goias</name>
      <address>
        <city>Goiânia</city>
        <state>Goiás</state>
        <zip>74605-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.scielo.br/pdf/csp/v24s2/11.pdf</url>
    <description>Publication of the article</description>
  </link>
  <link>
    <url>http://www.scielo.br/pdf/csp/v24n11/30.pdf</url>
    <description>Erratum of the title</description>
  </link>
  <reference>
    <citation>Wieringa FT, Dijkhuizen MA, van der Ven-Jongekrijg J, West CE, Muhilal, van der Meer JW. Micronutrient deficiency and supplementation in Indonesian infants. Effects on immune function. Adv Exp Med Biol. 2003;531:369-77.</citation>
    <PMID>12916807</PMID>
  </reference>
  <reference>
    <citation>Allen LH, Rosado JL, Casterline JE, López P, Muñoz E, Garcia OP, Martinez H. Lack of hemoglobin response to iron supplementation in anemic mexican preschoolers with multiple micronutrient deficiencies. Am J Clin Nutr. 2000 Jun;71(6):1485-94.</citation>
    <PMID>10837289</PMID>
  </reference>
  <reference>
    <citation>Hadler MC, Juliano Y, Sigulem DM. [Anemia in infancy: etiology and prevalence]. J Pediatr (Rio J). 2002 Jul-Aug;78(4):321-6. Portuguese.</citation>
    <PMID>14647764</PMID>
  </reference>
  <reference>
    <citation>Hadler MC, Colugnati FA, Sigulem DM. Risks of anemia in infants according to dietary iron density and weight gain rate. Prev Med. 2004 Oct;39(4):713-21.</citation>
    <PMID>15351537</PMID>
  </reference>
  <reference>
    <citation>Geltman PL, Meyers AF, Mehta SD, Brugnara C, Villon I, Wu YA, Bauchner H. Daily multivitamins with iron to prevent anemia in high-risk infants: a randomized clinical trial. Pediatrics. 2004 Jul;114(1):86-93.</citation>
    <PMID>15231912</PMID>
  </reference>
  <reference>
    <citation>Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet. 2006 Jan 14;367(9505):133-43. Erratum in: Lancet. 2006 Jan 28;367(9507):302.</citation>
    <PMID>16413877</PMID>
  </reference>
  <results_reference>
    <citation>Hadler MC, Sigulem DM, Alves Mde F, Torres VM. Treatment and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiânia, Goiás State, Brazil: a randomized controlled trial. Cad Saude Publica. 2008;24 Suppl 2:S259-71.</citation>
    <PMID>18670706</PMID>
  </results_reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <last_update_submitted>March 12, 2014</last_update_submitted>
  <last_update_submitted_qc>March 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Goias</investigator_affiliation>
    <investigator_full_name>Maria Claret Costa Monteiro Hadler</investigator_full_name>
    <investigator_title>PhD.</investigator_title>
  </responsible_party>
  <keyword>Anemia</keyword>
  <keyword>Iron deficiency anemia</keyword>
  <keyword>Infants</keyword>
  <keyword>Children</keyword>
  <keyword>Clinical trials</keyword>
  <keyword>Ferrous sulfate</keyword>
  <keyword>Folic acid</keyword>
  <keyword>Daycare centers</keyword>
  <keyword>Anaemia in children</keyword>
  <keyword>born at term</keyword>
  <keyword>non-twins</keyword>
  <keyword>with parental approval for participation in the study</keyword>
  <keyword>growth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

